Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$443M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$252M |
| 3 |
WCN
Waste Connections
WCN
|
+$176M |
| 4 |
Suncor Energy
SU
|
+$169M |
| 5 |
Microsoft
MSFT
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Scotiabank
BNS
|
+$302M |
| 2 |
Canadian Imperial Bank of Commerce
CM
|
+$203M |
| 3 |
TC Energy
TRP
|
+$197M |
| 4 |
Enbridge
ENB
|
+$147M |
| 5 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.06% |
| 2 | Energy | 10.15% |
| 3 | Industrials | 8.1% |
| 4 | Communication Services | 7.56% |
| 5 | Healthcare | 6.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
226
DELISTED
Allergan plc
AGN
| $115M | 0.07% |
499,278
-143,928
| -22% | -$33.2M |
|
|
ITC
227
DELISTED
ITC HOLDINGS CORP
ITC
| $115M | 0.07% |
2,445,763
-692,493
| -22% | -$30.7M |
|
228
Edwards Lifesciences
EW
$54B
| $114M | 0.07% |
3,440,277
-97,809
| -3% | -$3.35M |
|
229
Teva Pharmaceuticals
TEVA
$42.5B
| $114M | 0.07% |
2,267,984
+154,377
| +7% | +$8.22M |
|
230
Patrick Industries
PATK
$2.81B
| $114M | 0.07% |
4,239,482
-5,832
| -0.1% | -$130K |
|
231
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $113M | 0.07% |
1,001,314
+150,875
| +18% | +$16.7M |
|
232
Eaton
ETN
$178B
| $113M | 0.07% |
1,889,024
+164,060
| +10% | +$10.1M |
|
233
PUT
ExxonMobil
XOM
$657B
| $113M | 0.07% |
1,202,900
-502,100
| -29% | -$44.4M |
|
234
Cameco
CCJ
$43B
| $113M | 0.07% |
10,259,966
-2,251,291
| -18% | -$26.7M |
|
|
AGR
235
DELISTED
Avangrid, Inc.
AGR
| $112M | 0.07% |
2,429,096
+137,677
| +6% | +$5.67M |
|
236
Dominion Energy
D
$59.9B
| $112M | 0.07% |
1,432,645
+37,455
| +3% | +$2.72M |
|
237
Lamar Advertising Co
LAMR
$15.6B
| $111M | 0.07% |
1,678,332
-114,340
| -6% | -$7.22M |
|
238
West Pharmaceutical
WST
$24.7B
| $110M | 0.07% |
1,455,203
-109,240
| -7% | -$7.95M |
|
239
Dollar General
DG
$26.5B
| $108M | 0.06% |
1,152,838
+608,754
| +112% | +$52.5M |
|
|
VGR
240
DELISTED
Vector Group Ltd.
VGR
| $108M | 0.06% |
8,282,300
+93,313
| +1% | +$1.17M |
|
241
Lam Research
LRCX
$390B
| $108M | 0.06% |
12,804,290
-2,470,590
| -16% | -$19.8M |
|
242
Yum! Brands
YUM
$39.5B
| $107M | 0.06% |
1,802,063
+95,574
| +6% | +$5.63M |
|
243
iShares Core S&P Small-Cap ETF
IJR
$112B
| $107M | 0.06% |
1,842,864
+105,604
| +6% | +$6.02M |
|
244
Dr. Reddy's Laboratories
RDY
$10.4B
| $106M | 0.06% |
10,393,020
+1,117,655
| +12% | +$10.2M |
|
|
NLSN
245
DELISTED
Nielsen Holdings plc
NLSN
| $106M | 0.06% |
2,045,363
-20,263
| -1% | -$1.07M |
|
246
American Water Works
AWK
$27B
| $106M | 0.06% |
1,254,087
-1,632
| -0.1% | -$121K |
|
247
Kinross Gold
KGC
$32.3B
| $106M | 0.06% |
21,640,073
-595,322
| -3% | -$2.84M |
|
248
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.47B
| $106M | 0.06% |
1,589,857
+155,364
| +11% | +$10.4M |
|
|
GPT
249
DELISTED
Gramercy Property Trust
GPT
| $105M | 0.06% |
3,800,628
+197,674
| +5% | +$5.2M |
|
|
THS
250
DELISTED
Treehouse Foods
THS
| $105M | 0.06% |
1,022,778
-53,232
| -5% | -$4.91M |
|
Similar funds
Royal Bank of Canada's Q2 2016 Portfolio in Review
As of Q2 2016, Royal Bank of Canada held 6,889 positions worth $168B, up 4.5% from $161B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Royal Bank of Canada's Q2 2016 filing shows 414 new, 2,726 increased, 2,440 reduced and 410 closed positions. Its largest new stake was Brookfield Business Partners: 6,337,327 shares worth $77.6M. The largest sale was Scotiabank, an estimated $302M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Energy and Industrials.
- Royal Bank of Canada's largest Q2 2016 buy was Brookfield Business Partners: 6,337,327 shares worth $77.6M.
- Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $443M increase.
- Royal Bank of Canada's biggest Q2 2016 reduction was Scotiabank, cutting an estimated $302M.
- Royal Bank of Canada fully exited HEARTLAND PAYMENT SYSTEMS, INC. COM STK in Q2 2016, selling an estimated $59M.
- Royal Bank of Canada's ten largest holdings make up 22% of its $168B portfolio in Q2 2016.
- Royal Bank of Canada opened 414 new positions and closed 410 in Q2 2016.
- Royal Bank of Canada's portfolio value rose 4.5% quarter-over-quarter to $168B.
Based on Royal Bank of Canada's 13F filing for Q2 2016, filed 15 Aug 2016.